EMAIL THIS PAGE TO A FRIEND

Cancer research

Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198.


PMID 26363012

Abstract

Isocitrate dehydrogenase 1 (IDH1) is mutated in various types of human cancer to IDH1(R132H), a structural alteration that leads to catalysis of α-ketoglutarate to the oncometabolite D-2-hydroxyglutarate. In this study, we present evidence that small-molecule inhibitors of IDH1(R132H) that are being developed for cancer therapy may pose risks with coadministration of radiotherapy. Cancer cells heterozygous for the IDH1(R132H) mutation exhibited less IDH-mediated production of NADPH, such that after exposure to ionizing radiation (IR), there were higher levels of reactive oxygen species, DNA double-strand breaks, and cell death compared with IDH1 wild-type cells. These effects were reversed by the IDH1(R132H) inhibitor AGI-5198. Exposure of IDH1 wild-type cells to D-2-hydroxyglutarate was sufficient to reduce IDH-mediated NADPH production and increase IR sensitivity. Mechanistic investigations revealed that the radiosensitivity of heterozygous cells was independent of the well-described DNA hypermethylation phenotype in IDH1-mutated cancers. Thus, our results argue that altered oxidative stress responses are a plausible mechanism to understand the radiosensitivity of IDH1-mutated cancer cells. Further, they offer an explanation for the relatively longer survival of patients with IDH1-mutated tumors, and they imply that administration of IDH1(R132H) inhibitors in these patients may limit irradiation efficacy in this setting.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SML0839 AGI-5198, ≥98% (HPLC)
C27H31FN4O2
SAB4300514
Anti-H2AFX (Ab-139) antibody produced in rabbit, affinity isolated antibody
SAB4501369
Anti-Histone H2AX , C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB1100101
Anti-IDH1 (41-55) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB2101123
Anti-IDH1 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2101124
Anti-IDH1 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB4200522
Anti-IDH1 (C-terminal) antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
SAB2501682
Anti-IDH1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501422
Anti-IDH1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501423
Anti-IDH1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2701644
Anti-idh1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701749
Anti-idh1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4200592
Anti-IDH1 antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
HPA035248
Anti-IDH1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB3500511
Anti-IDH1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA057936
Anti-IDH1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
PLA0294
Goat anti-H2AX Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
WH0003014M5 Monoclonal Anti-H2AFX antibody produced in mouse, clone 3F4, purified immunoglobulin, buffered aqueous solution
SAB1403902 Monoclonal Anti-H2AFX, (N-terminal) antibody produced in mouse, clone 2H5, purified immunoglobulin, buffered aqueous solution
SAB4100064
Monoclonal Anti-IDH1 antibody produced in mouse, clone IDH1-A36, culture supernatant
AMAB90578
Monoclonal Anti-IDH1 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0219, purified immunoglobulin, buffered aqueous glycerol solution
PLA0023
Rabbit anti-H2AX Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
C8754
Thiamine pyrophosphate, ≥95%
C12H19ClN4O7P2S